Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00338832 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia
A Phase 3 study of Schizophrenia, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT00338832: Completed Phase 3 study of Schizophrenia, sponsored by Veterans Medical Research Foundation.
NCT00338832 is a Phase 3 study of Schizophrenia that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 86 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00338832, a Phase 3 study of Schizophrenia, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a lifestyle intervention in increasing physical activity and reducing disease symptoms in sedentary adults with schizophrenia.
Conditions Studied
Interventions
- BEHAVIORAL Physically Ready for Invigorating Movement Every Day (PRIME)
- BEHAVIORAL Program for Activity, Leisure Skills, and Socialization (PALSS)
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 3 |
What the finished NCT00338832 record still lists
NCT00338832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Physically Ready for Invigorating Movement Every Day (PRIME) is the first listed.
NCT00338832 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00338832 about?
NCT00338832 is a clinical study titled "Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia". This study will evaluate the effectiveness of a lifestyle intervention in increasing physical activity and reducing disease symptoms in sedentary adults with schizophrenia.
What is the current status of trial NCT00338832?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 86 participants. The study started on 2006-06. Estimated completion is 2011-08.
What conditions does trial NCT00338832 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT00338832?
The interventions under investigation include: Physically Ready for Invigorating Movement Every Day (PRIME) (BEHAVIORAL), Program for Activity, Leisure Skills, and Socialization (PALSS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00338832?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00338832 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00338832's enrollment target sits among peer trials
86 156th of 315 higher than 160 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
-
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
RECRUITING · Phase 3
-
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
RECRUITING · Phase 3
-
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
RECRUITING · Phase 3
-
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia